BRIEF published on 02/20/2026 at 12:05, 4 months 6 days ago Lupus Alpha Asset Management AG révèle sa participation dans Kitwave Group plc Actions Ordinaires Opérations Sur Titres Lupus Alpha Information Sur Les Investissements Groupe Kitwave
BRIEF published on 02/20/2026 at 12:05, 4 months 6 days ago Lupus Alpha Asset Management AG Discloses Stake in Kitwave Group plc Ordinary Shares Securities Dealings Investment Disclosure Lupus Alpha Kitwave Group
PRESS RELEASE published on 02/20/2026 at 12:00, 4 months 6 days ago Form 8.3 - Lupus alpha Asset Management AG: Kitwave Group plc Lupus alpha Asset Management AG discloses a 0.8371% ownership in Kitwave Group plc as of 19.02.2026 in accordance with Rule 8.3 of the Takeover Code Takeover Code Ownership Disclosure Lupus Alpha Asset Management AG Kitwave Group Plc 0.8371%
BRIEF published on 02/04/2026 at 12:00, 4 months 22 days ago Lupus alpha Asset Management AG révèle sa participation dans Kitwave Group plc Titres Code De Prise De Contrôle Divulgation Lupus Alpha Groupe Kitwave
BRIEF published on 02/04/2026 at 12:00, 4 months 22 days ago Lupus alpha Asset Management AG Discloses Position in Kitwave Group plc Securities Disclosure Takeover Code Lupus Alpha Kitwave Group
PRESS RELEASE published on 02/04/2026 at 11:55, 4 months 22 days ago Form 8.3 - Lupus alpha Asset Management AG: Kitwave Group plc Lupus alpha Asset Management AG discloses ownership of 1.1548% of Kitwave Group plc's 1p ordinary shares on 03.02.2026 Asset Management Ownership Disclosure 1p Ordinary Shares Lupus Alpha Kitwave Group Plc
BRIEF published on 08/08/2025 at 15:45, 10 months 17 days ago Lupus Alpha Asset Management dévoile sa participation dans Alpha Group International Code De Prise De Contrôle Formulaire 8.3 Divulgation Des Valeurs Mobilières Lupus Alpha Groupe Alpha International
BRIEF published on 08/08/2025 at 15:45, 10 months 17 days ago Lupus Alpha Asset Management Discloses Position in Alpha Group International Form 8.3 Takeover Code Securities Disclosure Lupus Alpha Alpha Group International
PRESS RELEASE published on 08/08/2025 at 15:40, 10 months 17 days ago Form 8.3 - Lupus alpha Asset Management AG: Alpha Group International plc Lupus alpha Asset Management AG discloses a 0.104% interest in Alpha Group International plc's 0.2p ordinary shares per Form 8.3 on 08-Aug-2025 Form 8.3 Disclosure Lupus Alpha Alpha Group International Plc Asset Management AG
BRIEF published on 06/26/2025 at 10:05, 1 year ago Lupus Alpha Asset Management AG Discloses Position in Alpha Group International plc Form 8.3 Takeover Code Shareholding Disclosure Lupus Alpha Alpha Group
Published on 06/26/2026 at 14:05, 1 hour 5 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 1 hour 10 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 2 hours 10 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 2 hours 25 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 14:00, 1 hour 10 minutes ago Hong Kong celebrates surge of global enterprises driving investment and opportunities
Published on 06/26/2026 at 14:00, 1 hour 10 minutes ago Bitcoin Group SE publishes 2025 Annual Report: Strategic realignment ensures future viability in the dynamic crypto market
Published on 06/26/2026 at 13:32, 1 hour 38 minutes ago Porsche ranks number one in J.D. Power 2026 U.S. Initial Quality Study
Published on 06/26/2026 at 13:30, 1 hour 39 minutes ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Published on 06/26/2026 at 13:30, 1 hour 40 minutes ago AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026
Published on 06/26/2026 at 07:00, 8 hours 10 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 8 hours 10 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
